These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36046647)

  • 1. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Oral Cavity Cancer.
    Tsai YT; Ko CA; Chen HC; Hsu CM; Lai CH; Lee YC; Tsai MS; Chang GH; Huang EI; Fang KH
    J Cancer; 2022; 13(10):3000-3012. PubMed ID: 36046647
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer.
    Zhuang J; Wang S; Wang Y; Wu Y; Hu R
    Int J Gen Med; 2024; 17():997-1005. PubMed ID: 38505146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study on the prognostic value of preoperative C-reactive protein to albumin ratio in patients with oral cavity squamous cell carcinoma.
    Fang KH; Lai CH; Hsu CM; Huang E; Tsai MS; Chang GH; Lee YC; Tsai YT
    PeerJ; 2020; 8():e9361. PubMed ID: 32587804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer.
    Zhang H; Shi J; Xie H; Liu X; Ruan G; Lin S; Ge Y; Liu C; Chen Y; Zheng X; Song M; Yang M; Zhang X; Shi HP
    Nutrition; 2023 Dec; 116():112191. PubMed ID: 37716090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Neutrophil Percentage-to-Albumin Ratio in Patients with Oral Cavity Cancer.
    Ko CA; Fang KH; Tsai MS; Lee YC; Lai CH; Hsu CM; Huang EI; Chang GH; Tsai YT
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer.
    Wang W; Gu J; Liu Y; Liu X; Jiang L; Wu C; Liu J
    Cancer Manag Res; 2022; 14():2803-2812. PubMed ID: 36160036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery.
    Takeda Y; Sugano H; Okamoto A; Nakano T; Shimoyama Y; Takada N; Imaizumi Y; Ohkuma M; Kosuge M; Eto K
    Asian J Surg; 2024 Mar; ():. PubMed ID: 38538400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Role of High-Sensitivity Modified Glasgow Prognostic Score for Patients With Operated Oral Cavity Cancer: A Retrospective Study.
    Tsai YT; Fang KH; Hsu CM; Lai CH; Chang SW; Huang EI; Tsai MS; Chang GH; Luan CW
    Front Oncol; 2022; 12():825967. PubMed ID: 35242712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Pre-Treatment CALLY Score Combined with EBV-DNA Levels for Prognostication in Non-Metastatic Nasopharyngeal Cancer Patients: A Clinical Perspective.
    Jiang T; Sun H; Xu T; Xue S; Xia W; Xiao X; Wang Y; Guo L; Lin H
    J Inflamm Res; 2024; 17():3353-3369. PubMed ID: 38803689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study on the potential of albumin/globulin ratio as a prognostic biomarker for oral cavity cancer patients.
    Wang YT; Fang KH; Hsu CM; Chang GH; Lai CH; Lee YC; Tsai MS; Huang EI; Tsai YT
    Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):227-238. PubMed ID: 32583177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study.
    Yang M; Lin SQ; Liu XY; Tang M; Hu CL; Wang ZW; Zhang Q; Zhang X; Song MM; Ruan GT; Zhang XW; Liu T; Xie HL; Zhang HY; Liu CA; Zhang KP; Li QQ; Li XR; Ge YZ; Liu YY; Chen Y; Zheng X; Shi HP
    Front Immunol; 2023; 14():1131496. PubMed ID: 37063910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer.
    Liu XY; Zhang X; Zhang Q; Ruan GT; Liu T; Xie HL; Ge YZ; Song MM; Deng L; Shi HP
    Support Care Cancer; 2023 Aug; 31(9):533. PubMed ID: 37610445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced Lung Cancer Inflammation Index Predicts Survival Outcomes of Patients With Oral Cavity Cancer Following Curative Surgery.
    Tsai YT; Hsu CM; Chang GH; Tsai MS; Lee YC; Huang EI; Lai CH; Fang KH
    Front Oncol; 2021; 11():609314. PubMed ID: 34660250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of C-reactive protein-albumin-lymphocyte (CALLY) index in patients with esophageal cancer.
    Ma R; Okugawa Y; Shimura T; Yamashita S; Sato Y; Yin C; Uratani R; Kitajima T; Imaoka H; Kawamura M; Morimoto Y; Okita Y; Yoshiyama S; Ohi M; Toiyama Y
    Surg Oncol; 2024 Apr; 53():102044. PubMed ID: 38335851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative prognostic nutritional index predicts prognosis of patients with oral cavity cancer.
    Fang KH; Chang SW; Lee YC; Huang EI; Lai CH; Chang GH; Tsai MS; Hsu CM; Tsai YT
    Oral Dis; 2022 Oct; 28(7):1816-1830. PubMed ID: 33690959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preoperative C-reactive protein-lymphocyte ratio and the prognosis of oral cavity squamous cell carcinoma.
    Ko CA; Fang KH; Hsu CM; Lee YC; Chang GH; Huang EI; Tsai MS; Tsai YT
    Head Neck; 2021 Sep; 43(9):2740-2754. PubMed ID: 33991004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Utility of Neck Lymph Node-to-Primary Tumor Standardized Uptake Value Ratio in Oral Cavity Cancer.
    Ho KW; Fang KH; Lu CH; Hsu CM; Lai CH; Liao CT; Kang CJ; Tsai YH; Tsai MS; Huang EI; Chang GH; Ko CA; Tsai MH; Tsai YT
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Tamagawa A; Kazama K; Kato A; Cho H; Nakazono M; Numata M; Kawahara S; Tanabe M; Morita J; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Apr; 44(4):1629-1636. PubMed ID: 38537973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer.
    Nakashima K; Haruki K; Kamada T; Takahashi J; Tsunematsu M; Ohdaira H; Furukawa K; Suzuki Y; Ikegami T
    Am Surg; 2024 Apr; ():31348241248693. PubMed ID: 38644521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictive value of the CRP-albumin-lymphocyte index for prognosis of critically ill patients with sepsis in intensive care unit: a retrospective single-center observational study.
    Zhang J; Zhao Q; Liu S; Yuan N; Hu Z
    Front Public Health; 2024; 12():1395134. PubMed ID: 38841671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.